Nayax revenue climbs 32% as recurring fees anchor growth
Nayax (NASDAQ:NYAX) reported a 32% increase in first-quarter revenue, bolstered by a steady shift toward digital payments and a growing base of automated self-service machines.
Nayax (NASDAQ:NYAX) reported a 32% increase in first-quarter revenue, bolstered by a steady shift toward digital payments and a growing base of automated self-service machines.
D-Wave Quantum (NYSE:QBTS) announced first-quarter 2026 bookings of $33.4 million, an increase of 1,994% compared to $1.6 million in the prior-year period.
Legend Biotech (NASDAQ:LEGN) announced that net trade sales of CARVYKTI, developed in collaboration with Johnson & Johnson’s Janssen unit, reached approximately $597 million in the quarter ended March 31, 2026.
Madison Air (NYSE:MAIR) generated $923.7 million in net sales for the quarter ended March 31, 2026, a 33.8% increase over the prior-year period.
Arvinas (NASDAQ:ARVN) reported that the U.S. Food and Drug Administration has approved VEPPANU (vepdegestrant) for the treatment of patients with ESR1-mutated ER+/HER2- advanced breast cancer.
Brightstar Lottery (NYSE:BRSL) reported first-quarter revenue of $587 million, a 1% increase year-over-year.
Lithium Argentina (NYSE:LAR) reported that its core asset, the Cauchari-Olaroz brine operation, produced 9,660 tonnes of lithium carbonate during the first quarter on a 100% basis.
eToro (NASDAQ:ETOR) posted a net contribution of $258 million for the quarter ended March 31, 2026, representing a 19% increase year-over-year.
LightInTheBox (NYSE:LITB) posted total net revenues of $52 million for the quarter ended March 31, 2026, an 11% increase compared to the same period last year.
Zebra Technologies (NASDAQ:ZBRA) reported net sales of $1,495 million for the first quarter ended April 4, 2026, representing a 14.3% increase over the prior-year period.
Keenova Therapeutics (NYSE:MNK) posted first-quarter 2026 net sales from continuing operations of $468 million.
Aramark (NYSE: ARMK) posted second-quarter revenue growth of 15% year-over-year, with organic revenue increasing by 12%.